|
Re: open access editorial in JCO accompanies article which MAY show equivalence of
Thank you for that article. BUT. The authors say much about PI3, her3 and so on. AND they still have only lapatinib and herceptin among targeted drugs? How will the chemotherapy have a supportive option if there are only 2 tatgeted drugs?
|